Sign in

Drugs for Neglected Diseases initiative (DNDi)

@dndi.org
7.2K followers 674 following 485 posts

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

PostsRepliesMedia
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 7h
🌍 Getting ready for #WHS2026! On 11 Oct, Dr Borna Nyaoke-Anoke, our Head of Mycetoma, will speak at a session to discuss the role of product development partnerships (PDPs) in advancing health equity. 🔗 Join us: worldhealthsummit.org/sessions/4f5... #WorldHealthSummit
001
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 25/09/2026
At #UNGA81, our Senior Policy Advocacy Manager Rachael Crockett explains why Article 9.5 of the WHO Pandemic Agreement could be a game changer for equitable access. 🔗 Read our intervention at UNGA: dndi.org/statements/2...
010
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 25/09/2026
What will it take to deliver therapeutics, diagnostics, & vaccines when the next outbreak hits? At #UNGA81, Rachel Cohen highlighted 3 key priorities for pandemic R&D and access. 👉 Read the @devex.com article: www.devex.com/news/sponsor... 👉 Watch the recording: www.youtube.com/watch?v=ZZ6j...
devex.com
Delivering the 100 Days Mission: From political commitment to practical readiness
Ahead of the U.N.High-Level Meeting on Pandemic Prevention, Preparedness and Response, experts warned that despite important progress, the 100 Days Mission remains fragile. The Ebola Bundibugyo outbre...
132
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 23/09/2026
Cutaneous #leishmaniasis is particularly difficult to treat in Ethiopia. A trial of thermotherapy and intralesional sodium stibogluconate found low cure rates, but thermotherapy may be a pragmatic choice when access to drugs is limited. link.springer.com/article/10.1... @bmc.springernature.com
link.springer.com
Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial - BMC Medicine
Background Cutaneous leishmaniasis (CL) is a significant public health challenge in Ethiopia with an estimated 20,000–30,000 new cases annually. Despite this high disease burden, management is constra...
010
Reposted by Drugs for Neglected Diseases initiative (DNDi)
International Pandemic Preparedness Secretariat @ippsecretariat.org · 21/09/2026
Our first panel session is on 'Delivering the #100DaysMission: Building the Enabling Ecosystem', with insights from @dndi.org, @cepi.net and @ippsecretariat.org. What are the capabilities, partnerships and investments needed to accelerate medical countermeasure readiness? #UNGA81
111
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 22/09/2026
@covid-moonshot.bsky.social & @asapdiscovery.bsky.social researchers tell us how they developed innovative approaches to IP, enabling open science drug discovery while ensuring non-exclusive manufacturing & equitable access. 🎧 open.spotify.com/episode/5CBi... #UNGA81 #PandemicPrep #OpenScience
184
Reposted by Drugs for Neglected Diseases initiative (DNDi)
Adam R Houston @healthlawadamh.bsky.social · 16/09/2026
New report worth reading from @dndi.org "Implementing Article 9.5 of the WHO #PandemicAgreement – building on current policy and practice for publicly funded R&D" dndi.org/wp-content/u...
Screenshot of the Executive Summary (too long for alt text) on page 2.
112
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 18/09/2026
Join us at #UNGA81 to discuss how to better prepare for pandemics through R&D & the 100 Days Mission. The 100 Days Mission aims to ensure the development & delivery of diagnostics, therapeutics, & vaccines within 100 days of a pandemic threat being identified. 🕗 8:00–9:30 a.m. ET 🔗 dvx.cm/bgxtab
002
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 11/09/2026
🔬 212 R&D and access partner institutions in 47 countries 🧪 41 clinical trial sites in 16 countries 🔎 To learn more about our activities: dndi.org/about/annual...
030
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 09/09/2026
Can oxfendazole help eliminate lymphatic filariasis? This Phase IIa proof‑of‑concept trial published in @springernature.com will evaluate its safety & ability to target adult filarial worms, helping guide development of new treatments. link.springer.com/article/10.1...
link.springer.com
A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms - Inf...
Introduction Lymphatic filariasis (LF) remains a significant public health concern, with India contributing nearly 55% of the global disease burden and placing approximately 487 million people at risk...
010
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 09/09/2026
Finding new treatments for #Chagas disease starts with better tools. This study developed a high‑throughput screening assay for T. cruzi & identified promising compounds that block protein synthesis, opening new avenues for drug discovery. @IJPara www.sciencedirect.com/science/arti...
sciencedirect.com
020
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 07/09/2026
As part of the 2025–26 #WithoutBordersMediaFellowship, journalist Rituparna Palit, a recipient of the MSF SouthAsia-DNDi Grant on #NTDs, explores #mycetoma in her latest feature for The Scientist: www.the-scientist.com/mycetoma-the...
the-scientist.com
Mycetoma: The Invisible Disease Beneath India's Soil | The Scientist
Years of wrong treatments, changing risk factors, and missing registries leave patients fighting a losing battle against a disabling disease.
001
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 04/09/2026
For the first time, dengue mosquitoes have been found breeding in London. As our climate warms, invasive mosquitoes are increasingly being detected in new areas. But despite this growing global threat, there is still no treatment for dengue. @bbcnewsunofficial.bsky.social www.bbc.com/news/article...
031
Reposted by Drugs for Neglected Diseases initiative (DNDi)
Medicines Patent Pool @medicinespatentpool.org · 04/09/2026
📅 9 Sept | 15:00-17:00 CEST 📍 @europarl.europa.eu& online How can public investment in health R&D deliver greater public benefit? Join MPP, @dndi.org & @saludporderecho.bsky.social to explore how access planning can help make publicly funded research more accessible and affordable. 🔗 bit.ly/3VbYRdS
032
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 03/09/2026
Our Asia Continental Lead, Sanjay Sarin, shares his perspectives with BioSpectrum Asia on the future of #NTD research in Asia, the rising burden of dengue, and the partnerships needed to accelerate the development of affordable, accessible treatments: www.biospectrumasia.com/opinion/29/2...
biospectrumasia.com
“Dengue will remain a major regional priority as we work with partners to expand treatment options across Asia”
“Dengue will remain a major regional priority as we work with partners to expand treatment options across Asia”
010
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 03/09/2026
Join us for a discussion on the growing practice of Access Planning in R&D, examining how it can help ensure that publicly funded R&D translates into timely public health-driven innovation and accessible, affordable, and available resulting health technologies. docs.google.com/forms/d/e/1F...
002
Reposted by Drugs for Neglected Diseases initiative (DNDi)
Prof. Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM) @eadirectordndi.bsky.social · 01/09/2026
Why do women remain underrepresented in clinical trials & how do we address the gaps? Join @dndi.org & IQVIA for a hybrid Media Science Café on gender-responsive R&D. 🗓️ Friday, 4th September, 2026 ⏲️ 11:00-13:00 EAT 🔗 Register here bit.ly/4cnjWIl #WomensHealth #HealthforAll
bit.ly
Welcome! You are invited to join a webinar: IQVIA-DNDi Media Science Cafe. After registering, you will receive a confirmation email about joining the webinar.
IQVIA and Drugs for Neglected Diseases initiative (DNDi) are partnering to host a media science cafe on Friday 4th September, 2026. The event will bring together researchers, regulators, policymakers,...
031
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 27/08/2026
New in @jamanetworkopen.com: Phase 2 results for Dengue-mAb show the first proof of concept for an antiviral as a treatment for confirmed dengue patients seeking medical care. At 5–7mg/kg, it rapidly cut viremia and fever, with no related serious AEs. 📄 Study: jamanetwork.com/journals/jam... 1/2
jamanetwork.com
Safety and Preliminary Efficacy of Dengue Monoclonal Antibody in Adult Patients
This randomized clinical trial examines dengue monoclonal antibody (Dengue-mAb) as a potential therapeutic option for adults infected with dengue virus in India.
111
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 27/08/2026
How to unlock the power of crowdsourced science to prepare for future coronavirus pandemics? Read our latest Drug Discovery Explained story on the @covid-moonshot.bsky.social and @asapdiscovery.bsky.social #openscience initiatives: 🔗 stories.dndi.org/drug-discove... #pandemicpreparedness
042
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 26/08/2026
swissinfo.ch takes a closer look at the strategic collaboration between DNDi, @mmv.org and @gardp.bsky.social as the global health landscape changes. 🔗Read here: www.swissinfo.ch/eng/new-trea...
swissinfo.ch
Swiss non-profit drugmakers team up as funding shrinks
As global health funding dries up and Big Pharma chases profits, who is left to develop lifesaving drugs for the world’s most neglected patients?
110
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 26/08/2026
We are proud to contribute to a new publication in the Journal of Translational Medicine on ICH E21 - guidance to improve the inclusion of pregnant and breastfeeding individuals in clinical trials and address evidence gaps in their care. link.springer.com/epdf/10.1186...
020
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 24/08/2026
Ten years ago, #mycetoma joined the @who.int list of neglected tropical diseases. So what has a decade of recognition made possible? And what still hasn't changed? Our new digital story brings the whole decade together. dndi.org/stories/2026... #MycetomaAt10 #BeatNTDs
dndi.org
Mycetoma at 10: What recognition made possible
2026 marks 10 years since mycetoma was formally recognized as a neglected tropical disease by the World Health Organization (WHO).
041
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 21/08/2026
When public money funds pandemic innovations, who benefits? Article 9.5 of the WHO Pandemic Agreement requires governments to develop policies on how publicly funded R&D can support equitable access to the products that result from it. Learn more ⤵️
051
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 19/08/2026
🦟 Kenya is currently experiencing an upsurge in #dengue fever, with cases concentrated in Garissa and Wajir counties and now spreading to the coastal region. The two counties have recorded several deaths since the outbreak began a couple of months ago. There is no specific treatment for dengue.
110
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 12/08/2026
Writer Daisy Hernández @dazeher.bsky.social joins our podcast to reflect on how her aunt’s experience with #Chagas disease exposed a wider public health failure affecting millions. We talk about the impact of NTDs, barriers to care, and the power of patient stories. open.spotify.com/episode/5COi...
open.spotify.com
Ep. 4 Daisy Hernandez on Chagas disease
The DNDi podcast · Episode
043
Reposted by Drugs for Neglected Diseases initiative (DNDi)
Prof. Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM) @eadirectordndi.bsky.social · 07/08/2026
A new sleeping sickness drug -acoziborole, recently got approved in the DRC. A single dose, 96% effective, developed & trial-tested by African scientists. This @nature.com op-ed argues this is a glimpse of Africa's growing leadership in medical innovation. @dndi.org 🔗 bit.ly/4giHUGN
nature.com
A new chapter for African medical innovation
The registration of a new sleeping sickness medicine illustrates how African scientists are helping to reshape every stage of drug development, from discovery to delivery.
052
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 31/07/2026
The issue isn’t only that millions live with #Chagas disease & cutaneous #leishmaniasis. The issue is that science struggles to respond fast enough. New study shows how collaborative platforms are reshaping research: cooperation, tech transfer & shared governance. 📖 www.scielo.br/j/physis/a/N...
scielo.br
021
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 31/07/2026
🌍 We’re #hiring! We are seeking an Executive Director to lead DNDi through our next phase of impact, innovation, & sustainable growth. 📌 Based in Geneva, Switzerland ✅ Full-time position – 100% 📆 Deadline: 15 September 2026 👉 Find out more and apply here: careers-dndi.icims.com/jobs/1246/ex...
011
Reposted by Drugs for Neglected Diseases initiative (DNDi)
Prof. Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM) @eadirectordndi.bsky.social · 29/07/2026
Good news! @WHO recommends new treatment guidelines for #leishmaniasis. East Africa: new combo treatment is 90%+ effective, cuts injections 34→14, hospitalization 60-90→14 days. South Asia: safer PKDL options, less toxic. Read more bit.ly/4x9OYv3 #BeatNTDs @dndi.org
bit.ly
WHO recommends new, better and safer treatment regimens for leishmaniasis
The World Health Organization (WHO) has issued major updates to its leishmaniasis treatment guidelines, introducing a new regimen for visceral leishmaniasis (VL/kala-azar) in eastern Africa and severa...
065
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 29/07/2026
New method for finding drugs for #Chagas disease: www.mdpi.com/1424-8247/19... By combining chemical similarity & AI protein structure predictions, the tool correctly identified known drug targets in most tests, helping speed up drug discovery while reducing time & cost @mdpiopenaccess.bsky.social
mdpi.com
031
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 24/07/2026
Dengue is no longer just a tropical disease. As the climate warms, the dengue-carrying mosquito is expanding its reach to new regions. Despite this growing global threat, there is still no specific treatment for dengue. Together with our partners, we're working to change this!
083
Reposted by Drugs for Neglected Diseases initiative (DNDi)
Global Health Solidarity Project @gh-solidarity.bsky.social · 23/07/2026
What happens when equity becomes negotiable, and solidarity becomes optional? During the April 2026 Open Forum, Michelle Childs from @dndi.org reflected on what it takes to make solidarity operational. Watch the excerpt here: www.youtube.com/watch?v=eIe2... #Health #Solidarity #Bioethics
013
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 23/07/2026
Last week, experts came together in a webinar to reflect on the last 10 years of #mycetoma progress and look at future priorities to tackle this devastating disease. If you missed it, listen to the audio recording here: www.youtube.com/watch?v=scke...
youtube.com
A decade of mycetoma advocacy and research (webinar audio recording)
YouTube video by Drugs for Neglected Diseases initiative (DNDi)
042
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 21/07/2026
In Latin America, 2025 was marked by important progress across our R&D portfolio & access initiatives. Our Latin America Activity Reports are now available. Explore the highlights & learn about our work across the region. 🔗 Portuguese: bit.ly/relatórioDNDi2025 🔗 Spanish: bit.ly/informeDNDi2025
020
Reposted by Drugs for Neglected Diseases initiative (DNDi)
Dr. Borna Nyaoke-Anoke @bornanyaoke.bsky.social · 20/07/2026
Join me at the Implantation Mycoses Symposium on 23rd July at #Infocus2026 as we discuss quality of life in #chromoblastomycosis, new #mycetoma findings from #Paraguay and updates on #lobomycosis. Also stop by the @dndi.org booth to learn more about our work on #NTDs
042
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 20/07/2026
10 years ago, #mycetoma was added to @who.int's list of #NTDs. That milestone was shaped by many advocates, including students who attended the World Health Assembly & refused to let the disease go unnoticed. Here's the full story: dndi.org/stories/2026...
dndi.org
Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows
In 2014, as an undergraduate student, Annie Liang attended the 67th World Health Assembly (WHA) as part of a youth delegation with Universities Allied for Essential Medicines (UAEM), where she and her...
022
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 17/07/2026
🤝Acoziborole was made possible through a strong partnership with Sanofi, which contributed expertise in regulatory affairs, manufacturing and supply - complementing our role in bringing deep knowledge of #SleepingSickness and experience conducting clinical trials across Africa.
020
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 16/07/2026
🎉 Our annual report is out! In 2025, we advanced work on 📋 33 projects, including 🔬 13 clinical trials in 6 disease areas, conducted across 📍 41 sites in 🌍 16 countries. To every partner and supporter standing with us: thank you 🙏 🔗 dndi.org/about/annual...
044
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 15/07/2026
For people with #Chagas disease, it can take years to know if treatment has worked. This study in @plos.org proposes a framework for using qPCR to identify treatment failure sooner & support the development of better therapies. journals.plos.org/plosntds/art...
journals.plos.org
Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring
Chagas disease remains a neglected global health problem with major diagnostic and therapeutic challenges. Progression from acute to chronic infection may lead to cardiac or digestive complications in...
051
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 14/07/2026
El diagnóstico oportuno es uno de los mayores desafíos frente a la enfermedad de Chagas. Este estudio presenta evidencia de una estrategia de tamizaje comunitaria que puede contribuir a cerrar esa brecha. 🔗Conoce los resultados→ revistas.unc.edu.ar/index.php/me...
000
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 14/07/2026
Have you registered for the upcoming webinar session on advancing research, diagnosis, & care for people with #mycetoma? Don't miss out on the conversation! 🗓️Thursday 16 July, 2026 🕒16:00-17:15 EAT / 1:00-2:15 GMT 🔗Register here➡️ us06web.zoom.us/webinar/regi... #MycetomaAt10 #BeatNTDs
121
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 13/07/2026
Acoziborole is the result of two decades of scientific innovation & collaboration with many partners & donors that have joined us on this long journey to fight #SleepingSickness. Hear from @drluispizarro.bsky.social, our ED, on how medical innovation can bring hope to people affected.⤵️ #1Dose1Cure
022
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 10/07/2026
We are delighted to announce that we are part of a drug discovery project on #mycetoma supported by @novo-nordisk.bsky.social and led by @erasmusmc.bsky.social in the Netherlands. Read more here: novonordiskfonden.dk/en/news/no-e...
012
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 10/07/2026
Africa's vulnerability during recent health emergencies highlights the need for stronger local R&D. This @naturemedicine.bsky.social comment argues for regionally coordinated hubs to drive research, development and manufacturing across Africa. www.nature.com/articles/s41...
nature.com
Inspiring, shaping and sustaining an African research & development agenda - Nature Medicine
Why Africa needs regional R&D hubs for basic science and translation research to accelerate local manufacturing.
021
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 09/07/2026
👏 The United Nations Human Rights Council adopts for the first time a resolution on NTDs: www.who.int/news/item/07...
who.int
Historic resolution on neglected tropical diseases adopted by the United Nations Human Rights Council
Resolution 62/27 on “Human rights and neglected tropical diseases” was adopted today by the Human Rights Council (HRC) at its sixty-second session in Geneva.
073
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 08/07/2026
We're pleased to announce that we have signed a licensing agreement with the @seruminstindia.bsky.social to support the development of what could become the world's first specific treatment for dengue. Read the press release: www.dndi.org/press-releas...
062
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 07/07/2026
Why do some drug candidates enter cells more easily than others? This study explores how molecular shape, flexibility and internal interactions influence permeability, offering insights for designing better macrocyclic medicines. doi.org/10.1021/acs....
doi.org
What Is in a Structure? Cell Permeability and Solubility of Series of Macrocycles and Linear Matched Pairs
Macrocycles are a highly interesting modality to modulate difficult-to-drug targets, but often reside in chemical space where obtaining sufficient cell permeability and solubility is challenging. We have determined permeability across Caco-2 cells, aqueous solubility and log D for four series of semipeptidic macrocycles and one series of linear matched molecular pairs. By using X-ray crystallography, NMR spectroscopy, and computational chemistry, unexpected permeability differences between series and matched pairs were explained by differences in conformational preferences that determine the formation of intramolecular interactions. Macrocycles that formed intramolecular NH–π interactions and hydrogen bonds were more permeable than matched pairs unable to form such interactions. The elevated permeability of linear compounds was concluded to result from their greater conformational flexibility, allowing them to shield amide bonds and expose nonpolar groups to a greater extent than their macrocyclic matched pairs. Solubility was less dependent on specific intramolecular interactions and was predominantly low at log D >2.5.
010
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 03/07/2026
It's been 10 years since @who.int recognized #mycetoma as an #NTD. Join us for a webinar as we reflect on improving diagnosis, treatment & access. 📆 16 July, 16:00 EAT Register➡️ us06web.zoom.us/webinar/regi... #MycetomaAt10
222
Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 01/07/2026
🤝 How do you use crowdsourcing to design medicines that could work against coronaviruses? In this video, Fanny Escudié, our Senior Discovery Project Manager, shows how open science, AI, and global collaboration are accelerating discovery.
032
Reposted by Drugs for Neglected Diseases initiative (DNDi)
SciDev.net @scidevnet.bsky.social · 30/06/2026
Doctors say cryptococcal meningitis linked to #HIV is treatable, but access to medicines and diagnostics remains uneven where deaths are highest. Supported by @dndi.org #SciComm
scidev.net
Cryptococcal meningitis: Africa's neglected HIV killer
Doctors say more diagnostic testing is needed for cryptococcal meningitis, a deadly disease affecting people with HIV.
032